Wei CX, Althouse SK, Mamdani H, Hanna NH, et al. Association of Immune-Related Adverse Events With Efficacy in Consolidation Nivolumab Plus Ipilimumab or Nivolumab Alone After Chemoradiation in Patients With Unresectable Stage III Nonsmall Cell Lung Cancer: An Exploratory Analysis From the Big 10 Ca Clin Lung Cancer 2024 Dec 21:S1525-7304(24)00270.
PMID: 39824659